Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials
- PMID: 16556322
- PMCID: PMC1449870
- DOI: 10.1186/1745-6215-7-6
Lead editorial: trials - using the opportunities of electronic publishing to improve the reporting of randomised trials
Abstract
This editorial introduces the new online, open access, peer-reviewed journal Trials. The journal considers manuscripts on any aspect of the design, performance, and findings of randomised controlled trials in any discipline related to health care, and also encourages the publication of protocols. Trialists will be able to provide the necessary detail for a true and complete scientific record. They will be able to communicate not only all outcome measures, as well as varying analyses and interpretations, but also in-depth descriptions of what they did and honest reflections about what they learnt. Trials also encourages articles covering generic issues related to trials, for example focussing on the design, conduct, analysis, interpretation, or reporting.
References
-
- Horton R. The scientific paper: fraudulent or formative? Abstract presented at Third International Congress on Biomedical Peer Review and Global Communications, Prague, September 1997.
-
- Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, for the CONSORT Group The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001;134:663–694. - PubMed
-
- Plint AC, Moher D, Schulz K, Altman DG, Morrison A. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. Fifth International Congress on Peer Review and Biomedical Publication, Chicago, September 16–18, 2005.
Publication types
LinkOut - more resources
Full Text Sources
